arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2105.07285stat.ME
收藏

关于修改反倾销措施的分歧

Disagreement Concerning Effect-Measure Modification

Jake Shannin, Babette A. Brumback

摘要:

分层因素,如年龄和性别,可以改变治疗和暴露对研究结果风险的影响。几种效应度量,包括相对风险、风险比、优势比和风险差,可用于测量这种改变。众所周知,效果测量的选择可以确定效果测量修改的存在和方向。我们发现,考虑相反的结果-例如,恢复而不是死亡-可能同样影响效果测量修改。事实上,如果研究结果的相对风险和相反结果的相对风险在效应-测量修正的方向上一致,那么两个累积风险比、风险差和比值比也会一致。当风险从均匀(0,1)分布中随机抽样时,这种情况发生的概率为5/6。不同意是很可能的,研究人员考虑一个相对风险也应该考虑其他和进一步的讨论,如果他们不同意。(If如果可能,研究人员还应报告估计的风险。我们通过对HCV、COVID-19和黑色素瘤治疗后破产的案例研究提供了例子。

英文摘要:

Stratifying factors, like age and gender, can modify the effect of treatments and exposures on risk of a studied outcome. Several effect measures, including the relative risk, hazard ratio, odds ratio, and risk difference, can be used to measure this modification. It is known that choice of effect measure may determine the presence and direction of effect-measure modification. We show that considering the opposite outcome -- for example, recovery instead of death -- may similarly influence effect-measure modification. In fact, if the relative risk for the studied outcome and the relative risk for the opposite outcome agree about the direction of effect-measure modification, then so will the two cumulative hazard ratios, the risk difference, and the odds ratio. When risks are randomly sampled from the uniform (0,1) distribution, the probability of this happening is 5/6. Disagreement is probable enough that researchers considering one relative risk should also consider the other and further discussion if they disagree. (If possible, researchers should also report estimated risks.) We provide examples through case studies on HCV, COVID-19, and bankruptcy following melanoma treatment.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑